Natural ingredient leaders combine to launch new bioactives business
The Oterra Group announces the launch of Akay Bioactives: a new brand for its business unit offering clinically substantiated actives, specialty actives, and botanical extracts for the health and nutrition industry.
The Oterra Group, the world’s leading supplier of natural colors, completed its acquisition of Akay Natural Ingredients, a prominent natural ingredients manufacturer, in October 2022. Newly formed Akay Bioactives integrates Akay’s Spiceuticals business and the Oterra Group’s NutriPhy business into one portfolio.
“I’m extremely excited about the creation of Akay Bioactives,” said Frederik Errebo, Head of Business Unit Akay Bioactives. “Our combined portfolio, scientific expertise, unique technologies, and commercial strengths allow us to create more value for our customers and the society at large by providing natural, sustainable, and efficacious solutions that enhance human health. Natural bioactives is a rapidly growing space, and we’re uniquely positioned to further capture share and accelerate our growth with our strong positioning deeply rooted in science and technology.”
Dr. Balu Maliakel, Managing Director, Akay Natural Ingredients said: “I’m very proud and excited to see the creation of Akay Bioactives. We’re a pioneer in this field and have worked intensively on bringing innovate, science-backed ingredients to the market for 15 years. Together with Oterra, we’re even stronger. I look forward to seeing the business further prosper and will be dedicated to ensuring continuously reliable operations in our sites in India and support the innovation efforts of Akay Bioactives.”
Mads Dehlsen Winther, Interim CEO, Oterra Group added: “This is an important step for us in line with our acquisition strategy. Bioactives is a key area for Oterra, and by creating a leading player in the field, we see significant growth potential in the years to come.”
Akay Bioactives transforms the best of what nature provides into premier bioactives with substantiated health benefits powered by clinical research, advanced technology, and a vertically integrated value chain. The business unit has an ambitious double-digit growth target.
Headquartered in the US, Akay Bioactives has a global footprint of 11 locations, including four manufacturing facilities and two R&D labs. The business unit serves 120+ customers across 30+ countries, offering a portfolio comprised of 50+ ingredients, 30+ patents (granted and applied), and 70+ scientific publications substantiating the efficacy and safety of its bioactives.
Media Contact:
Febin George
Akay Bioactives
Global Commercial Development Lead
M: +91 944 772 4997
E: febin.george@akaybioactives.com
Akay Bioactives is a global pioneer in natural and clinically substantiated bioactive ingredients. Driven by our purpose to amplify nature’s ability to enhance human health, we sustainably transform natural resources into bioactives with substantiated health outcomes. Our unparalleled clinical research and cutting-edge delivery technologies unlock the full potential of nature’s hidden abilities. With a vertically integrated approach and an agile partnership model, we power our partners to accelerate and enhance innovation to support in-demand claims, improve health outcomes, and drive new consumer trends. Akay Bioactives is a brand of the Oterra Group.
Tags:
